A carregar...

Nanoliposomal delivery of cytosolic phospholipase A(2) inhibitor arachidonyl trimethyl ketone for melanoma treatment

Drug resistance and toxicity are major limitations of cancer treatment and frequently occurs in melanoma therapy. Nanotechnology can decrease drug resistance by improving drug delivery, with limited toxicity. This study details the development of nanoparticles containing arachidonyl trifluoromethyl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Gowda, Raghavendra, Dinavahi, Saketh S., Iyer, Soumya, Banerjee, Shubhadeep, Neves, Rogerio I., Pameijer, Colette R., Robertson., Gavin P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5899023/
https://ncbi.nlm.nih.gov/pubmed/29317343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2017.12.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!